Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug [Pharmacological Research Oct 2018]
Posted byTerri Fettinger
This is a widget ready area. Add some and they will appear here.
